Repligen Corp (RGEN)
139.51
+0.90
(+0.65%)
USD |
NASDAQ |
Nov 04, 16:00
139.51
0.00 (0.00%)
After-Hours: 20:00
Repligen Enterprise Value: 7.541B for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 7.541B |
| October 31, 2024 | 7.298B |
| October 30, 2024 | 7.416B |
| October 29, 2024 | 7.332B |
| October 28, 2024 | 7.463B |
| October 25, 2024 | 7.364B |
| October 24, 2024 | 7.349B |
| October 23, 2024 | 7.478B |
| October 22, 2024 | 7.851B |
| October 21, 2024 | 8.135B |
| October 18, 2024 | 8.008B |
| October 17, 2024 | 7.739B |
| October 16, 2024 | 7.516B |
| October 15, 2024 | 7.898B |
| October 14, 2024 | 7.790B |
| October 11, 2024 | 7.553B |
| October 10, 2024 | 7.310B |
| October 09, 2024 | 7.426B |
| October 08, 2024 | 7.340B |
| October 07, 2024 | 7.428B |
| October 04, 2024 | 7.435B |
| October 03, 2024 | 7.565B |
| October 02, 2024 | 7.800B |
| October 01, 2024 | 7.940B |
| September 30, 2024 | 8.113B |
| Date | Value |
|---|---|
| September 27, 2024 | 7.951B |
| September 26, 2024 | 8.021B |
| September 25, 2024 | 7.597B |
| September 24, 2024 | 7.779B |
| September 23, 2024 | 7.643B |
| September 20, 2024 | 7.785B |
| September 19, 2024 | 7.943B |
| September 18, 2024 | 7.733B |
| September 17, 2024 | 7.417B |
| September 16, 2024 | 7.619B |
| September 13, 2024 | 7.618B |
| September 12, 2024 | 7.727B |
| September 11, 2024 | 7.809B |
| September 10, 2024 | 7.994B |
| September 09, 2024 | 7.870B |
| September 06, 2024 | 8.015B |
| September 05, 2024 | 7.909B |
| September 04, 2024 | 7.870B |
| September 03, 2024 | 7.719B |
| August 30, 2024 | 8.231B |
| August 29, 2024 | 8.221B |
| August 28, 2024 | 7.923B |
| August 27, 2024 | 7.957B |
| August 26, 2024 | 7.992B |
| August 23, 2024 | 8.000B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.929B
Minimum
Nov 06 2019
17.34B
Maximum
Sep 23 2021
9.189B
Average
9.113B
Median
Enterprise Value Benchmarks
| West Pharmaceutical Services Inc | 22.63B |
| QuidelOrtho Corp | 5.086B |
| Perspective Therapeutics Inc | 524.04M |
| Xtant Medical Holdings Inc | 102.06M |
| Catheter Precision Inc | 2.058M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 3.321M |
| Revenue (Quarterly) | 154.07M |
| Total Expenses (Quarterly) | 152.59M |
| EPS Diluted (Quarterly) | 0.06 |
| Gross Profit Margin (Quarterly) | 49.82% |
| Profit Margin (Quarterly) | 2.16% |
| Earnings Yield | -0.03% |
| Normalized Earnings Yield | -0.5422 |